Company Filing History:
Years Active: 2016-2017
Title: Liyuan Zhu: Innovator in Pharmaceutical Compounds
Introduction
Liyuan Zhu is a notable inventor based in Shanghai, China. He has made significant contributions to the field of pharmaceutical compounds, particularly in the development of innovative treatments for neurological diseases. With a total of 2 patents, his work focuses on compounds that target dopamine and serotonin receptors.
Latest Patents
Liyuan Zhu's latest patents include the following:
1. **Diaryl[A, G]quinolizidine compound, preparation method therefor, pharmaceutical composition, and uses thereof** - This invention relates to a diarylo[a,g]quinolizidine compound, its preparation method, and its applications in developing experimental model drugs related to dopamine and 5-HT receptors. It aims to provide a medicament for treating or preventing diseases associated with these receptors.
2. **Hexahydrodibenzo[a,g]quinolizine compound, preparation method thereof, pharmaceutical composition and use thereof** - This patent describes a novel hexahydrodibenzo[a,g]quinoline compound and its derivatives. The invention includes a method for preparing the compound, which has shown promising effects in preventing and treating neurological diseases, particularly those linked to dopamine and serotonin receptors.
Career Highlights
Liyuan Zhu has worked with prominent organizations such as Kingsound & Partner and the Chinese Academy of Sciences. His experience in these institutions has allowed him to advance his research and contribute to the development of innovative pharmaceutical solutions.
Collaborations
Liyuan Zhu has collaborated with notable colleagues, including Hong Tao Liu and Xuechu Zhen, who is a woman. These collaborations have enriched his research and expanded the impact of his inventions.
Conclusion
Liyuan Zhu's contributions to the field of pharmaceutical compounds demonstrate his commitment to advancing medical science. His innovative patents hold the potential to significantly improve treatments for neurological diseases.